Ajooni Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1.73	68.3	4.28	3.09	0.57	2.44
Short-Term Investments	-	4.4	0.02	3.26	1.18	1.6
Cash & Short-Term Investments	1.73	72.7	4.3	6.35	1.75	4.04
Cash Growth	-99.02%	1589.22%	-32.25%	262.20%	-56.61%	112.78%
Accounts Receivable	218.5	162.16	129.59	205.51	138.4	137.12
Other Receivables	-	5.52	0.79	3.24	0.12	1.1
Receivables	414.41	167.68	130.38	208.75	138.52	138.22
Inventory	249.46	239.87	153.67	69.94	58.82	53.76
Prepaid Expenses	-	1.37	3.14	1.41	0.27	0.15
Other Current Assets	1.62	138.42	31.78	60.26	19.9	18.12
Total Current Assets	667.22	620.04	323.28	346.71	219.27	214.29
Property, Plant & Equipment	228.77	112.26	112.43	65.51	62.05	51.62
Long-Term Investments	32.88	34.94	21.36	37.37	7.04	11.48
Other Intangible Assets	3.9	4.79	-	-	-	-
Long-Term Deferred Tax Assets	3.84	3.79	3.12	2.72	1.82	1.47
Long-Term Deferred Charges	-	-	-	-	-	1.41
Other Long-Term Assets	200.7	174.69	15	135	-	0
Total Assets	1,137	950.51	475.2	587.31	290.18	280.26
Accounts Payable	104.13	29.3	13.38	98.46	66.22	52.84
Accrued Expenses	2.21	5.81	2.68	3.21	1.84	1.23
Short-Term Debt	86.38	-	-	28.69	18.2	39.62
Current Portion of Long-Term Debt	-	-	4.86	5.62	9.54	9.24
Current Income Taxes Payable	12.48	10.24	8.75	5.42	4.48	1.5
Other Current Liabilities	3.51	2.86	0.44	10.69	0.32	0.35
Total Current Liabilities	208.7	48.21	30.11	152.09	100.59	104.78
Long-Term Debt	16.74	19.4	16.82	17.47	25.76	18.98
Pension & Post-Retirement Benefits	1.01	2.11	1.2	1.06	-	-
Other Long-Term Liabilities	-	-	0	0.01	-0	-
Total Liabilities	226.46	69.72	48.13	170.62	126.35	123.76
Common Stock	344.49	344.49	175.23	175.23	100.06	100.06
Additional Paid-In Capital	-	431.86	177.97	177.97	30.07	30.07
Retained Earnings	-	120.07	86.9	66.2	55	44.51
Comprehensive Income & Other	566.36	-15.63	-13.02	-2.7	-21.31	-18.13
Shareholders' Equity	910.85	880.79	427.08	416.69	163.82	156.51
Total Liabilities & Equity	1,137	950.51	475.2	587.31	290.18	280.26
Total Debt	103.12	19.4	21.68	51.77	53.51	67.84
Net Cash (Debt)	-101.39	53.31	-17.37	-45.42	-51.75	-63.79
Net Cash Per Share	-0.99	0.31	-0.20	-0.76	-1.02	-1.28
Filing Date Shares Outstanding	164.8	172.24	87.61	87.61	50.03	50.03
Total Common Shares Outstanding	164.8	172.24	87.61	87.61	50.03	50.03
Working Capital	458.52	571.83	293.18	194.63	118.68	109.51
Book Value Per Share	5.53	5.11	4.87	4.76	3.27	3.13
Tangible Book Value	906.95	876	427.08	416.69	163.82	156.51
Tangible Book Value Per Share	5.50	5.09	4.87	4.76	3.27	3.13
Land	-	59.15	59.15	20.21	11.17	11.17
Buildings	-	28.94	18.32	18.51	18.51	-
Machinery	-	77.68	71.23	60.92	59.02	41.74
Construction In Progress	-	2.93	9.25	2.62	-	15.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.